Behavioural despair in rats: A new model sensitive to antidepressant treatments

Acebal, 1976, A double blind comparative trial of nomifensin and desimipramine in depression, European J. Clin. Pharmacol., 10, 109, 10.1007/BF00609468

Angst, 1974, Ergebnisse eines offenen und eines Doppelblindversuches von Nomifensin im Vergleich zu Imipramin, Arch. Psychiat. Nervenkr., 219, 265, 10.1007/BF00342052

Ayd, 1969, Clinical evaluation of a new tricyclic antidepressant iprindole, Dis. Nerv. Syst., 30, 818

Benson, 1975, The forgotten treatment modality in bipolar illness: psychotherapy, Dis. Nerv. Syst., 36, 634

Bowlby, 1977, The making and breaking of affectional bonds. I. Aetiology and psychopathology in the light of attachment theory, Brit. J. Psychiat., 130, 201, 10.1192/bjp.130.3.201

Coppen, 1976, Clinical and pharmacological effects of treatment with a new antidepressant, Arzneim. Forsch., 26, 1166

Coston, 1975, Etude neuroélectrophysiologique chez le chat d'un nouveau psychotrope: latoloxatone, Thérapie, 30, 725

De Alarcon, 1969, Severe depressive mood changes following slow-release intramuscular fluphenazine injection, Brit. Med. J., 3, 564, 10.1136/bmj.3.5670.564

Fann, 1972, Effect of iprindole on amine uptake in man, Arch. Gen. Psychiat., 26, 158, 10.1001/archpsyc.1972.01750200062013

Floru, 1976, Doppelblind-studie mit dem neuen Antidepressivum Viloxazin im Vergleich zu Imipramin bei 50 stationären Patientinnen, Arzneim. Forsch., 26, 1170

Fluckman, 1969, The pharmacology of iprindole, a new antidepressant, Psychopharmacologia, 15, 169, 10.1007/BF00411167

Gouret, 1977, Intéraction de divers psychotropes avec cinq effects de la réserpine chez la souris et le chat: ptose palpébrale, hypothermie, hypomotilité, catalepsie et pointes pontogéniculo-occipitales: intérêt des tests en psychopharmacologie, J. Pharmacol. (Paris), 8, 333

Gouret, 1975, Activité de la toloxatone, d'antidépresseurs et de divers autres antagonistes de la réserpine sur trois épreuves de comportement chez la souris traitée par la nialamide, Thérapie, 30, 225

Gouret, 1973, Profil psychopharmacologique d'un antidépresseur potential appartenant à la série de l'hydroxymethyl-5-oxazolidinone-2, Thérapie, 28, 1197

Greenwood, 1975, Animal pharmacology of viloxazine (Vivalan), J. Intern. Med. Res., 3, 18

Harlow, 1974, Induced depression in monkeys, Behav. Biol., 12, 273, 10.1016/S0091-6773(74)91475-8

Helmchen, 1967, Depressive Syndrome im Verlauf neuroleptischer Therapie, Nervenarzt, 38, 455

Hunt, 1974, Nomifensine: a new potent inhibitor of dopamine uptake into synaptosomes from rat brain corpus striatum, J. Pharm. Pharmacol., 26, 370, 10.1111/j.2042-7158.1974.tb09294.x

Hoffmann, 1973, 8-Amino-4-methyl-1-4-phenyl-1,2,3,4-tetrahydroisoquinoline, a new antidepressant, Arzneim. Forsch., 23, 45

Ilaria, 1975, Convulsive therapy and other biological treatments, 271

Itil, 1972, Clinical and EEG effects of GB 94, a ‘tetracyclic’ antidepressant (EEG model: discovery of a new psychotropic drug), Curr. Therap. Res. Exp., 14, 395

Jalfre, 1971, Effects of some centrally acting agents in rats after intraventricular injections of 6-hydroxydopamine, 333

Jalfre, 1974, Methods for assessing the interaction of agents with 5-hydroxytryptamine neurons and receptors in the brain, Advan. Biochem. Psychopharmacol., 10, 121

Jaskari, 1977, Three double blind comparative trials of mianserine (ORG GB 94) and amitryptyline in the treatment of depressive illness, Pharmakopsychiat. Neuropsychopharmakol., 10, 101, 10.1055/s-0028-1094526

Kafoe, 1973, The effect of a new tetracyclic antidepressant compound, ORG GB 94, on the turnover of dopamine, noradrenaline and serotonin in the rat brain, Arch. Intern. Pharmacodyn. Therap., 206, 389

Kan, 1977, Study of a new oxazolidinone with original MAO inhibiting properties, 149

Koe, 1976, Molecular geometry of inhibitors of the uptake of catecholamines amd serotonin in synaptosomal preparations of rat brain, J. Pharmacol. Exptl. Therap., 199, 649

LeDouarec, 1970, Pharmacology and biochemistry of fenfluramine, 75

Lippmann, 1976, Effects of viloxazine, an antidepressant agent, on biogenic amine uptake mechanisms and related activities, Can. J. Physiol. Pharmacol., 54, 494, 10.1139/y76-069

Loosen, 1976, Kombinierte Schlafentzugs/Chlorimipramine Behandlung endogener Depressionen, Arzneim. Forsch., 26, 1177

Maj, 1976, Central effects of mianserin and danitracen—new antidepressant drugs of unknown mechanism of action, 163

Maj, 1976, Central action of nomifensine, Pol. J. Pharmacol. Pharm., 28, 557

Mallion, 1972, 2-(2-ethoxyphenoxymethyl)tetrahydro-1,4-oxazine hydrochloride, a potential psychotropic agent, Nature, 238, 157, 10.1038/238157a0

Martin, 1973, Un nouvel antidepresseur, le 69276: essai thérapeutique, originalité du produit, Inform. Psychiat., 49, 1023

Miller, 1975, Depression and learned helplessness in man, J. Abnorm. Psychol., 84, 228, 10.1037/h0076720

Moizeszowicz, 1977, Controlled trial of nomifensin (HOE 984) and viloxazine in the treatment of depression in the elderly, J. Clin. Pharmacol., 17, 81, 10.1002/j.1552-4604.1977.tb04589.x

Mouret, 1969, Paradoxical sleep rebound in the rat. Effects of physical procedures involved in intracisternal injection, Brain Res., 15, 501, 10.1016/0006-8993(69)90170-X

Murphy, 1976, The serotoninergic neurotransmitter system in the affective disorders — and evaluation of the antidepressant and antimanic effects of fenfluramine, Proc. 10th Congr. C.I.N.P., 125

Murphy, 1975, A comparative clinical trial of ORG GB 94 and imipramine in the treatment of depression in general practice, J. Intern. Med. Res., 3, 251, 10.1177/030006057500300406

Pinder, 1975, Fenfluramine: a review of its pharmacological properties and therapeutic efficacy in obesity, Drugs, 10, 241, 10.2165/00003495-197510040-00001

Porsolt, 1977, Depression: a new animal model sensitive to antidepressant treatments, Nature, 266, 730, 10.1038/266730a0

Post, 1976, Effects of sleep deprivation on mood and central amine metabolism in depressed patients, Arch. Gen. Psychiat., 33, 627, 10.1001/archpsyc.1976.01770050077012

Raiteri, 1976, Comparative study of the effects of mianserin, a tetracyclic antidepressant, and of imipramine on uptake and release of neurotransmitters in synaptosomes, J. Pharm. Pharmacol., 28, 483, 10.1111/j.2042-7158.1976.tb02770.x

Rickels, 1973, Iprindole and imipramine in non psychotic depressed outpatients, Brit. J. Psychiat., 123, 329, 10.1192/bjp.123.3.329

Ross, 1971, A comparison of the inhibitory activities of iprindole and imipramine on the uptake of 5-hydroxytryptamine and noradrenaline in brain slices, Life Sci., 10, 1267, 10.1016/0024-3205(71)90325-0

Rudolf, 1977, Antidepressive Behandlung mittels Schlafentzug, Nervenarzt, 48, 1

Samanin, 1975, The effect of nomifensine on the depletion of brain serotonin and catecholamines induced respectively by fenfluramine and 6-hydroxydopamine in rats, European J. Pharmacol., 34, 377, 10.1016/0014-2999(75)90266-6

Schildkraut, 1972, Neuropsychopharmacology of the affective disorders, Ann. Rev. Pharmacol., 13, 427, 10.1146/annurev.pa.13.040173.002235

Schilgen, 1976, Totaler und partieller Schlafentzug in der Behandlung von Depressionen, Arzneim. Forsch., 26, 1171

Scott, 1973, Separation in infant dogs: emotional response and motivational consequences, 3

Seligman, 1975

Seligman, 1967, Failure to escape traumatic shock, J. Exptl. Psychol., 74, 1, 10.1037/h0024514

Soubrié, 1971, Open-field chez le rat: interrelations entre locomotion exploration et émotivité, J. Pharmacol. (Paris), 2, 457

Soubrié, 1976, Diazépam et amnésie, Rev. Méd., 19, 1082

Suttel, 1975, Etude clinique d'un nouvel antidépresseur: le 69276, Actual. Psychiat., 2

Toumisto, 1977, Nomifensine and its derivatives as possible tools for studying amine uptake, European J. Pharmacol., 42, 101, 10.1016/0014-2999(77)90348-X

Trulson, 1976, Behavioral evidence for the rapid release of CNS serotonin by PCPA and fenfluramine, European J. Pharmacol., 36, 49, 10.1016/0014-2999(76)90266-1

Van Riezen, 1972, Different central effects of 5-HT antagonists mianserin and cyproheptadine, Arch. Intern. Pharmacodyn. Therap., 198, 256

1975, 3

Vogel, 1975, A. Review of REM sleep deprivation: REM sleep reduction effects on depression syndromes, Arch. Gen. Psychiat., 32, 749, 10.1001/archpsyc.1975.01760240077006

Vogel, 1976, Mianserin versus amitriptyline. A double blind trial evaluated by the AMP System, Intern. Pharmacopsychiat., 11, 25, 10.1159/000468209

Wheatley, 1975, Controlled clinical trial of a new antidepressant (ORG GB 94) of novel chemical formulation, Curr. Therap. Res. Clin. Exp., 18, 849

Wielosz, 1976, Uptake of 14C-5-hydroxytryptamine by human and rat platelets and its pharmacological inhibition. A comparative kinetic analysis, Naunyn-Schmiedeb. Arch. Pharmacol., 296, 59, 10.1007/BF00498840